Network Topology Reveals Key Cardiovascular Disease Genes

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Sarajlić, Anida ^a   Janjić, Vuk ^a   Stojković, Neda ^b   Radak, Djordje ^b   Pržulj, Nataša ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; E1A ASSOCIATED P300 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 5; MYC PROTEIN; PROTEIN C JUN; PROTEIN KINASE FYN; PROTEIN MDM2; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SP1;

ABL1 GENE; ACTB GENE; AR GENE; ARTICLE; C JUN GENE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE GENE; CAUSE OF DEATH; CREBBP GENE; CTNNB1 GENE; DRIVER GENE; DRUG TARGETING; EGFR GENE; EP300 GENE; ESR1 GENE; FYN GENE; GENE; GENE IDENTIFICATION; GRB2 GENE; HDAC1 GENE; HDAC5 GENE; HSP90AA1 GENE; HSP90AA2 GENE; IKBKG GENE; JUN GENE; MDM2 GENE; METHODOLOGY; ONCOGENE MYC; PATHOGENESIS; PIK3R1 GENE; PREDICTION; PROTEIN PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION NETWORK; SHC1 GENE; SMAD2 GENE; SMAD3 GENE; SP1 GENE; SRC GENE; STATISTICAL MODEL; TP53 GENE; TUMOR SUPPRESSOR GENE; YWHAQ GENE; YWHAZ GENE;

CARDIOVASCULAR DISEASES; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HUMANS; PROTEIN INTERACTION MAPS; REPRODUCIBILITY OF RESULTS;

EID: 84881564126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071537     Document Type: Article

References (60)

1. Jonsson P, Bates P, (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22: 2291-2297.
2. Ideker T, Sharan R, (2008) Protein networks in disease. Genome Research 18: 644-652.
3. Aragues R, Sander C, Oliva B, (2008) Predicting cancer involvement of genes from heterogeneous data. BMC Bioinformatics 9: 172.
4. Milenković T, Memišević V, Ganesan A, Pržulj N, (2010) Systems-level cancer gene identification from protein interaction network topology applied to melanogenesis-related functional genomics data. Journal of the Royal Society Interface 44: 353-350.
5. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: a report from the american heart association. Circulation 125: e3-e5.
6. Schnabel R, Baccarelli A, Lin H, Ellinor P, Benjamin E, (2012) Next steps in cardiovascular disease genomic researchsequencing, epigenetics, and transcriptomics. Clinical chemistry 58: 113-126.
7. Goldschmidt-Clermont P, Ginsburg G, Seo D, (2006) Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. Journal of the American College of Cardiology 48: 227-235.
8. Cui Z, Dewey S, Gomes AV, (2011) Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases. Am J Cardiovasc Dis 1(3): 274-292.
9. Ping P, Chan DW, Srinivas P, (2010) Advancing cardiovascular biology and medicine via proteomics: Opportunities and present challenges of cardiovascular proteomics. Circulation 121: 2326-2328.
10. Mallick P, Kuster B, (2010) Proteomics: a pragmatic perspective. Nat Biotechnol 28: 695-709.
11. Camargo A, Azuaje F, (2007) Linking gene expression and functional network data in human heart failure. PLoS ONE 2(12): e1347.
12. Camargo A, Azuaje F, (2008) Identification of dilated cardiomyopathy signature genes through gene expression and network data integration. Genomics 92: 404-413.
13. Jin G, Zhou X, Wang H, Zhao H, Cui K, et al. (2008) The knowledge-integrated network biomarkers discovery for major adverse cardiac events. J Proteome Res 7(9): 4013-4021.
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. Nature Genetics 25: 25-29.
15. Zhang L, Li X, Tai J, Li W, Chen L (2012) Predicting candidate genes based on combined network topological features: A case study in coronary artery disease. PLoS ONE 7.
16. Goh K, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proceedings of the National Academy of Sciences USA 104: 8685-8690.
17. Yidirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M, (2007) Drug-target network. Nature Biotechnology 25: 1119-1126.
18. Radivojac P, Peng K, Clark WT, Peters BJ, Mohan A, et al. (2008) An integrated approach to inferring gene-disease associations in humans. Proteins 72: 1030-7.
19. Goldenberg A, Mostafavi S, Quon G, Boutros PC, Morris QD, (2011) Unsupervised detection of genes of influence in lung cancer using biological networks. Bioinformatics 27: 3166-3172.
20. Milenković T, Pržulj N, (2008) Uncovering biological network function via graphlet degree signatures. Cancer Informatics 4: 257-273.
21. Ho H, Milenković T, Memišević V, Aruri J, Pržulj N, et al. (2010) Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets. BMC Systems Biology 4: 84.
22. Janjić V, Pržulj N, (2012) The core diseasome. Molecular Biosystems 8: 2614-2625.
23. Ashworth A, Lord CJ, Reis-Filho JS, (2011) Genetic interactions in cancer progression and treatment. Cell 145: 30-38.
24. Seidman SB, (1983) Network structure and minimum degree. Social Networks 5: 269-287.
25. Batagelj V, Zaversnik M, (2003) An o(m) algorithmfor cores decomposition of networks. Symposium A Quarterly Journal In Modern Foreign Literatures cs.DS/0310: 1-10.
26. Kuchaiev O, Stevanovic A, Hayes W, Pržulj N (2011) GraphCrunch 2: Software tool for network modeling, alignment and clustering. BMC Bioinformatics 12.
27. Milenković T, Lai J, Pržulj N (2008) Graphcrunch: a tool for large network analyses. BMC Bioinformatics 9.
28. Kuchaiev O, Milenković T, Memišević V, Hayes W, Pržulj N, (2010) Topological network alignment uncovers biological function and phylogeny. Journal of the Royal Society Interface 7: 1341-1354.
29. Memišević V, Pržulj N, (2012) C-graal: Common-neighbors-based global graph alignment of biological networks. Integrative Biology 4: 734-743.
30. Milenković T, Leong Ng W, Hayes W, Pržulj N, (2010) Optimal network alignment with graphlet degree vectors. Cancer Informatics 9: 121-137.
31. Du P, Feng G, Flatow J, Song J, Holko M, et al. (2009) From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics 25: i63-i68.
32. Pržulj N, Corneil DG, Jurisica I, (2004) Modeling interactome: Scale-free or geometric? Bioinformatics 20: 3508-3515.
33. Pržulj N, (2007) Biological network comparison using graphlet degree distribution. Bioinformatics 23: e177-e183.
34. Guerrero C, Milenković T, Pržulj N, Jones JJ, Kaiser P, et al. (2008) Characterization of the yeast proteasome interaction network by qtax-based tag-team mass spectrometry and protein interaction network analysis. PNAS, Proceedings of the National Academy of Sciences USA 105: 13333-13338.
35. Maier M, von Luxburg U, Hein M (2012) How the result of graph clustering methods depends on the construction of the graph. ESAIM: Probability and Statistics eFirst.
36. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
37. King AD, Pržulj N, Jurisica I, (2004) Protein complex prediction via cost-based clustering. Bioinformatics 20: 3013-3020.
38. Ji X, Tang J, Halberg R, Busam D, Ferriera S, et al. (2010) Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study. BMC Cancer 10: 426.
39. Youn A, Simon R, (2011) Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27: 175-181.
40. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, et al. (2010) An integrated approach to uncover drivers of cancer. Cell 143: 1005-1017.
41. Gerzanich V, Ivanova S, Simard JM, (2003) Early pathophysiological changes in cerebral vessels predisposing to stroke. Clinical Hemorheology and Microcirculation 29: 291-294.
42. Birks EJ, Latif N, Enesa K, Folkvang T, Luong LA, et al. (2008) Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Research 79: 472-480.
43. Zhang Q, He X, Chen L, Zhang C, Gao X, et al. (2012) Synergistic regulation of p53 by mdm2 and mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development. The Journal of Pathology 228: 416-428.
44. Chen KC, Liao YC, Hsieh IC, Wang YS, Hu CY, et al. (2012) Oxldl causes both epigenetic modification and signaling regulation on the microrna-29b gene: novel mechanisms for cardiovascular diseases. Journal of Molecular and Cellular Cardiology 52: 587-595.
45. van de Laar IMBH, van der Linde D, Oei EHG, Bos PK, Bessems JH, et al. (2012) Phenotypic spectrum of the smad3-related aneurysms-osteoarthritis syndrome. Journal of Medical Genetics 49: 47-57.
46. van der Linde D, van de Laar IMBH, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, et al. (2012) Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic smad3 variants. Journal of the American College of Cardiology 60: 397-403.
47. Gomez D, Coyet A, Ollivier V, Jeunemaitre X, Jondeau G, et al. (2011) Epigenetic control of vascular smooth muscle cells in marfan and non-marfan thoracic aortic aneurysms. Cardiovascular Research 89: 446-456.
48. Bjørnstad JL, Skrbic B, Marstein HS, Hasic A, Sjaastad I, et al. (2012) Inhibition of smad2 phosphorylation preserves cardiac function during pressure overload. Cardiovascular Research 93: 100-110.
49. Chang C, Zhang C, Zhao X, Kuang X, Tang H, et al. (2012) Differential regulation of mitogenactivated protein kinase signaling pathways in human with different types of mitral valvular disease. Journal of Surgical Research.
50. Souders CA, Bowers SLK, Banerjee I, Fuseler JW, Demieville JL, et al. (2012) c-myc is required for proper coronary vascular formation via cell- and gene-specific signaling. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 1308-1319.
51. Min J, Reznichenko M, Poythress RH, Gallant CM, Vetterkind S, et al. (2012) Src modulates contractile vascular smooth muscle function via regulation of focal adhesions. Journal of Cellular Physiology 227: 3585-3592.
52. Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, et al. (2011) Brca1 is an essential regulator of heart function and survival following myocardial infarction. Nature Communications 2: 593.
53. Haldar SM, Lu Y, Jeyaraj D, Kawanami D, Cui Y, et al. (2010) Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Science Translational Medicine 2: 26ra26.
54. Reiling E, Lyssenko V, Boer JMA, Imholz S, Verschuren WMM, et al. (2012) Codon 72 polymorphism (rs1042522) of tp53 is associated with changes in diastolic blood pressure over time. European Journal of Human Genetics 20: 696-700.
55. Zawada AM, Rogacev KS, Hummel B, Grün OS, Friedrich A, et al. (2012) Supertag methylationspecific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosisrelated genes. Circulation Cardiovascular Genetics 5: 611-620.
56. Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, et al. (2003) The role of the grb2-p38 mapk signaling pathway in cardiac hypertrophy and fibrosis. Journal of Clinical Investigation 111: 833-841.
57. Ahrens I, Lip G, Peter K, (2010) New oral anticoagulant drugs in cardiovascular disease. Thrombosis & Haemostasis 104: 49.
58. Burnier M, Brunner H, (2000) Angiotensin ii receptor antagonists. Lancet 355: 637.
59. Ju H, Scammel-La Fleur T, Dixon I, (1996) Altered mrna abundance of calcium transport genes in cardiac myocytes induced by angiotensin ii. Journal of molecular and cellular cardiology 28: 1119.
60. Gabay M, Jain R, (2002) Role of antibiotics for the prevention of cardiovascular disease. The Annals of Pharmacotherapy 36: 1629-1636.